UNI-EN 13:ANNUAL AUDITED INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31 DECEMBER 2016
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 13 | / | 2017 | |||||||
| Date of issue: | 2017-03-31 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| ANNUAL AUDITED INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31 DECEMBER 2016 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| ANNUAL AUDITED INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31 DECEMBER 2016 1. Financial Statements 2. Notes to the Financial Statements 3. Management report 4. Templates of the financial reports approved by the Bulgarian FSC 5. Declaration of the responsible directors 6. Auditors’ report 7. Report regarding the application of the remuneration policy 8. Corporate governance declaration | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFARM_annual_audited_financial_report_31122016.zip SFARM_annual_audited_financial_report_31122016.zip | ANNUAL AUDITED INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31 DECEMBER 2016 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2017-03-31 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 6.61 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
